AzTrials
AzTrials

Patellofemoral Pain SyndromeAITR-PFPSNCT07775157

AI Based Telerehabilitation for Patellofemoral Pain Syndrome

A study testing AI Based Telerehabilitation and Conventional Physiotherapy in people with Patellofemoral Pain Syndrome and Anterior Knee Pain Syndrome, run by University of Faisalabad at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain in young, active adults and is often aggravated by prolonged sitting, stair use, squatting, and running. Exercise-based physiotherapy is the standard first-line treatment, but access to regular in-person supervision can be limited. Read more about this study

Who is it for?
Ages 18 to 40 years
What is being tested?
AI Based Telerehabilitation and Conventional Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 sitePakistan
Study dates
24 Apr 2026to 7 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age between 18 and 40 years.
  • Body mass index 18.5-24.9 kg/m².
  • Insidious (non-traumatic) onset of anterior knee pain, with positive Clark test.
  • Pain during at least two of: running, jumping, squatting, kneeling, walking up/down stairs, or prolonged sitting.
  • At least two positive clinical findings among apprehension test, patellar compression test, crepitus on compression, peripatellar tenderness, or pain on resisted knee extension.
  • SNAPPS questionnaire score ≥6.
Show all 9Show fewer
  • Sitting in the same position >4 hours/day for over a year.
  • Knee pain for at least 1 month, with activity-related pain above mild on NPRS.
  • Access to a mobile phone and internet.

Who cannot join

  • Meniscal, ligamentous, or tendon injury of the knee.
  • Patellar fracture, subluxation, or dislocation.
  • Surgical or conservative treatment of the affected knee within the previous 6 months.
  • Neuromuscular, metabolic, or rheumatologic disorder.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • University of Faisalabad

    Faisalabad, Punjab Province, 3800

Other trials in Pakistan

About this study

Official title: Effectiveness and Useability of AI Based Telerehabilitation on Patellofemoral Pain Syndrome

Patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain in young, active adults and is often aggravated by prolonged sitting, stair use, squatting, and running. Exercise-based physiotherapy is the standard first-line treatment, but access to regular in-person supervision can be limited. This study compares two ways of delivering the same evidence-based exercise programme for PFPS: AI-based telerehabilitation, delivered remotely through the Physitrack platform with AI-assisted movement screening (MediaPipe), and conventional face-to-face physiotherapy. The study aimed to determine whether AI-based telerehabilitation is as effective as, or more effective than, conventional physiotherapy in reducing pain and improving physical function, and to evaluate how usable participants found the telerehabilitation platform

Read the detailed description

This randomized controlled trial enrolled 48 individuals with PFPS (mean age 29.48 ± 6.40 years, range 19-40; 28 female, 20 male), screened using a structured demographic/SNAPPS questionnaire and an AI based movement screen built on Google's MediaPipe pose-estimation model, which tracked angle of knee. Eligible participants were randomly allocated using the gold-fish-bowl method to the Telerehabilitation Group (n=24; mean age 29.33 ± 6.75, 16 female/8 male) or the Conventional Physiotherapy group (n=24; mean age 29.63 ± 6.16, 12 female/12 male). Both groups followed an identical exercise protocol delivered three times weekly for four weeks (12 sessions of approximately 40-45 minutes). The Telerehabilitation Group received the programme remotely via the Physitrack platform and PhysiApp, including video-guided exercises, an AI-enabled assistant, remote monitoring, and messaging with the treating physiotherapist. The Conventional Physiotherapy group received the identical exercise content face to face in a physiotherapy clinic under direct therapist supervision. Outcomes were assessed at baseline and after 4 weeks: pain (Numeric Pain Rating Scale, NPRS), knee function (Anterior Knee Pain/Kujala Scale, AKPS), knee-related quality of life (KOOS Patellofemoral Subscale, KOOS-PF), knee flexion/extension range of motion and quadriceps (Q) angle via goniometer, and for the telerehabilitation group only platform usability (Telehealth Usability Questionnaire, TUQ). Data were analyzed in SPSS version 22 using paired and independent-samples t-tests or their non-parametric equivalents as appropriate. All 48 randomized participants completed the trial with no dropout.

Being tested
AI Based Telerehabilitation, Conventional Physiotherapy
Keywords
Telerehabilitation, Artificial Intelligence, Mediapipe, Physitrack
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI Based TelerehabilitationBehavioural

    A structured PFPS exercise protocol delivered remotely through the Physitrack platform and PhysiApp, supported by an AI-enabled movement assistant for screening/feedback, video demonstrations, progress tracking, and secure messaging with the treating physiotherapist. 3 sessions/week for 4 weeks.

  • Conventional PhysiotherapyOther

    The identical PFPS exercise protocol delivered face-to-face by a certified physiotherapist in a clinical setting, with direct supervision, real-time correction of technique, and verbal feedback. 3 sessions/week for 4 weeks.

Study groups in NCT07775157
Study groupRoleWhat they receive
Telerehabilitation GroupExperimentalParticipants (n=24) received a structured, evidence-based PFPS exercise programme delivered remotely via the Physitrack app, with an AI-enabled movement assistant, video-guided sessions, remote monitoring, and therapist messaging. 3 sessions/week for 4 weeks (12 sessions, ~40-45 min each).
Receives: Behavioral: AI Based Telerehabilitation
Conventional PhysiotherapyExperimentalParticipants (n=24) received the identical exercise programme delivered face-to-face in a physiotherapy clinic under direct supervision of a certified physiotherapist, with real-time correction and verbal feedback. 3 sessions/week for 4 weeks (12 sessions, ~40-45 min each).
Receives: Other: Conventional Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Intensity

    Measured using the Numeric Pain Rating Scale (NPRS), an 11-point scale where 0 = "no pain" and 10 = "worst imaginable pain".

    Measured: Baseline (Session 1) and post-treatment (Week 4, after 12th session)

  2. Functional disability

    Measured using the Anterior Knee Pain Scale and Kujala Questionnaire (AKPS), a 13-item, 0-100 self-report measure of patellofemoral pain and function.

    Measured: Baseline (Session 1) and post-treatment (Week 4, after 12th session)

Secondary outcomes (2)
  1. Range of Motion

    Active knee flexion, knee extension, and quadriceps (Q) angle measured with a universal goniometer.

    Measured: Baseline (Session 1) and post-treatment (Week 4, after 12th session)

  2. Telehealth Useability

    Measured using the Telehealth Usability Questionnaire (TUQ), a 21-item, 7-point measure of usefulness, ease of use, interface quality, reliability, and satisfaction.

    Measured: Baseline (Session 1) and post-treatment (Week 4, after 12th session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2026
  2. Study start24 Apr 2026
  3. Primary completion7 Jul 2026
  4. Study completion7 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study followed a parallel-group randomized controlled design in which participants were allocated to one of two groups and remained in that group for the duration of the study. Both groups received conventional physiotherapy as standard care, while the experimental group received additional exteroceptive stimulation. Interventions were delivered concurrently over a four-week period, and outcomes were assessed at baseline and after completion of the intervention. No crossover between groups occurred.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07775157
Sponsor's protocol ID
2024-MS-PT-060
Acronym
AITR-PFPS
Status last verified
Aug 2026
First submitted
15 Aug 2026
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Amirabadi N, Hessam M, Monjezi S et al. (2024) Effectiveness of telerehabilitation intervention to improve pain and physical function in people with patellofemoral pain syndrome: Study protocol for a randomized controlled trial. Trials 25(1): 195. Butt A, Niazi R, Jamil A et al. (2022) Prevalence of patellofemoral pain syndrome in females and its impact on daily activities. Rawal Medical Journal 47(2): 385. Bhatti SA, Waseem I, Akhtar M et al. (2022) Association of patellofemoral syndrome with prolonged duration of sitting among teachers: A cross sectional survey. Pakistan BioMedical Journal 5(5): 321-324. Hong QM, Wang HN, Liu XH et al. (2023) Home-based exercise program and health education in patients with patellofemoral pain: A randomized controlled trial. BMC Musculoskeletal Disorders 24(1): 896. Kasitinon D, Li W-X, Wang EXS et al. (2021) Physical examination and patellofemoral pain syndrome: An updated review. Current Reviews in Musculoskeletal Medicine 14(6): 12-406. Kim JS, Kim YW, Woo YK et al. (2021) Validity of an artificial intelligence assisted motion analysis system using a smartphone for evaluating weight bearing activities in individuals with patellofemoral pain syndrome. Journal of Musculoskeletal Science and Technology 5(1): 34-40. Lee JH, Shin KH, Lee GB et al. (2023) Comparison of functional outcomes between supervised rehabilitation and telerehabilitation in female patients with patellofemoral pain syndrome during the COVID-19 pandemic. International Journal of Environmental Research and Public Health 20(3): 22-33. Moros I, Boutsikari EC, Plakoutsis G et al. (2025) Reliability and Validity Measures of the Patellofemoral Subscale KOOS-PF in Greek Patients with Patellofemoral Pain. Journal of Functional Morphology and Kinesiology 10(1): 44. Nilmart P, Vongsirinavarat M, Khawsuwan P et al. (2024) Impact of telehealth based therapeutic exercise on pain, functional performance and dynamic knee valgus in young adult females with patellofemoral pain:

Questions about this trial

What is this clinical trial studying?

A study testing AI Based Telerehabilitation and Conventional Physiotherapy in people with Patellofemoral Pain Syndrome and Anterior Knee Pain Syndrome, run by University of Faisalabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Intensity (time frame: Baseline (Session 1) and post-treatment (Week 4, after 12th session)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07775157, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in